Health News

Health News

Please note that these news articles link to external websites.

Your Vote

There is currently no poll for this section.

 

This service contains links to third party websites. EPG Patient Direct is not in a position to verify this information and cannot be held responsible for the accuracy of the content contained.

   
 

Renal Anaemia

What is Renal AnaemiaRenal Anaemia?
Anaemia is defined as a reduction of the number of circulating red blood cells to below a certain threshold level. It is also described as a low haemoglobin concentration or a low volume of packed red cells2.

Chronic Kidney Disease (CKD) is characterised by a gradual and permanent loss of kidney function that worsens as it progresses from stages 1 to 5. One of the most common complications of CKD is anaemia. Anaemia in patients with CKD causes debilitating weakness and fatigue, altered cognitive function, and a negative impact on quality of life and wellbeing.1

Renal anaemia is secondary to chronic kidney disease (CKD) and it appears early in the course of CKD, worsening as it progresses.

Because renal anaemia impairs the delivery and utilization of oxygen to tissues and organs throughout the body, it has a wide range of effects on both quality of life and overall health and well being.2

CKD-related anaemia is a major public health concern. It is associated with an increased risk of morbidity, mortality and hospitalisation, diminished physical well-being and reduced patient quality of life.3-6

Diagnosis of Renal Anaemia
Diagnosing renal anaemia is critical in establishing early and appropriate treatment in patients.

Treament for Renal Amaemia
The priority in the treatment of anaemia is to correct the underlying factors that caused the anaemia and the specific treatment strategy depends on the cause of the anaemia.

There are a number of treatment guidelines available which provide information on the management of anaemia and CKD related anaemia. Treatment of renal anaemia can significantly improve overall health in patients with chronic kidney disease (CKD).

Useful links

  • National Kidney Foundation 
    The National Kidney Foundation, a major voluntary nonprofit health organization, is dedicated to preventing kidney and urinary tract diseases, improving the health and well-being of individuals and families affected by kidney disease and increasing the availability of all organs for transplantation.
  • UK National Kidney Federation
  • Official journal of the International Society of Nephrology 
    NPG publishes journals and online databases across the life, physical and applied sciences and, most recently, clinical medicine. Content encompasses daily news from award-winning journalists, expert opinion and practical methodology, and more high impact research and reviews than any science publisher.
  • The Renal Association (UK)
    The Renal Association is the professional body for United Kingdom nephrologists (renal physicians, or kidney doctors) and renal scientists in the UK. It is active in the planning and development of renal services and nephrology in Britain. It is also involved in the promotion and dissemination of research and education relating to the specialty. The Association was founded in 1950, when its activities were restricted to holding scientific meetings.
  • European Renal Association - European Dialysis and Transplant Association (ERA-EDTA)
    The ERA-EDTA is one of the fastest growing Medical Association whose purpose is to encourage and to report advances in the field of clinical nephrology, dialysis, renal transplantation and related subjects.

Source: EPG guide www.epgonline.org/renal-anaemia/renal-anaemia.cfm

References:
1. Lefebvre P, Vekeman F, Sarokhan B, Enny C, Provenzano R, Cremieux PY. Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa. Curr Med Res Opin. 2006;22:1929-1937.
2. NAAC (National Anemia Action Council) Anemia monograph. Available at http://anemia.org/professionals/monograph/ [Accessed June 2008].
3. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis. 1996;28:53–61.
4. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis. 1999;34:125–134.
5. Ofsthun N, Labrecque J, Lacson E, Keen M, Lazarus JM. The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients. Kidney Int. 2003;63:1908–1914.
6. Perlman RL, Finkelstein FO, Liu L, Roys E, Kiser M, Eisele G, Burrows-Hudson S, Messana JM, Levin N, Rajagopalan S, Port FK, Wolfe RA, Saran R. Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis. 2005;45:658–666.

Last Updated 25-05-2010